Rhumbline Advisers raised its holdings in Teligent, Inc. (NASDAQ:TLGT) by 0.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,622 shares of the company’s stock after buying an additional 200 shares during the quarter. Rhumbline Advisers owned 0.09% of Teligent worth $454,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Teligent by 10.4% in the 1st quarter. Vanguard Group Inc. now owns 1,976,891 shares of the company’s stock worth $15,440,000 after purchasing an additional 185,624 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Teligent by 124.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 1,043,046 shares of the company’s stock worth $9,544,000 after purchasing an additional 577,635 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Teligent by 6.1% in the 1st quarter. Geode Capital Management LLC now owns 417,679 shares of the company’s stock worth $3,262,000 after purchasing an additional 24,149 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Teligent in the 1st quarter worth about $612,000. Finally, Teachers Advisors LLC grew its holdings in shares of Teligent by 1.0% in the 4th quarter. Teachers Advisors LLC now owns 65,454 shares of the company’s stock worth $433,000 after purchasing an additional 648 shares during the last quarter. 66.00% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have recently weighed in on TLGT shares. Deutsche Bank AG reaffirmed a “hold” rating and issued a $9.00 target price (up previously from $8.00) on shares of Teligent in a report on Monday, July 17th. Canaccord Genuity started coverage on shares of Teligent in a report on Monday, July 31st. They issued a “buy” rating and a $11.00 target price on the stock. ValuEngine lowered shares of Teligent from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Roth Capital set a $9.00 target price on shares of Teligent and gave the stock a “buy” rating in a report on Wednesday, August 23rd. Finally, BidaskClub lowered shares of Teligent from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $9.33.

Teligent, Inc. (TLGT) opened at 7.12 on Friday. The firm’s market cap is $380.14 million. The company’s 50-day moving average is $6.90 and its 200 day moving average is $6.90. Teligent, Inc. has a 12 month low of $5.75 and a 12 month high of $7.99.

Teligent (NASDAQ:TLGT) last released its earnings results on Tuesday, August 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.02 by ($0.04). Teligent had a negative net margin of 11.36% and a positive return on equity of 1.49%. The business had revenue of $18.40 million during the quarter, compared to the consensus estimate of $20.11 million. During the same quarter in the prior year, the firm earned $0.02 EPS. The business’s revenue was up 7.4% on a year-over-year basis. Equities research analysts expect that Teligent, Inc. will post $0.07 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/06/rhumbline-advisers-has-454000-holdings-in-teligent-inc-tlgt.html.

Teligent Company Profile

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent, Inc. (NASDAQ:TLGT).

Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Receive News & Stock Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related stocks with our FREE daily email newsletter.